Tema Etfs LLC Buys 1,614 Shares of Intuitive Surgical, Inc. $ISRG

Tema Etfs LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,526 shares of the medical equipment provider’s stock after buying an additional 1,614 shares during the period. Tema Etfs LLC’s holdings in Intuitive Surgical were worth $4,262,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $25,000. Kilter Group LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter valued at $27,000. Greykasell Wealth Strategies Inc. bought a new stake in Intuitive Surgical during the 3rd quarter worth $27,000. Olistico Wealth LLC bought a new stake in Intuitive Surgical during the 4th quarter worth $28,000. Finally, Caitlin John LLC acquired a new position in Intuitive Surgical in the 3rd quarter worth about $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 2,362 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the completion of the transaction, the senior vice president owned 3,554 shares in the company, valued at approximately $1,772,308.72. This trade represents a 39.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president owned 409 shares in the company, valued at $202,438.64. This trade represents a 50.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 32,943 shares of company stock valued at $17,279,568 over the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Recent fundamentals — Intuitive reported a strong quarter (EPS and revenue beats, healthy margins and ~19% year-over-year revenue growth), which underpins investor confidence in growth and helps justify the stock’s premium P/E.
• Positive Sentiment: Analyst / thematic support — Motley Fool coverage frames ISRG as a high-growth pick and highlights the company’s durable competitive position in surgical robotics, which can support longer-term investor demand. Intuitive Surgical Maintains Edge Despite Security Breach
• Neutral Sentiment: Recent trading moves — Coverage of ISRG’s intraday/settlement gains shows short-term buyer interest, but volume and market context suggest this is a continuation of momentum trading rather than a new fundamental catalyst. ISRG Rises But Trails Market
• Negative Sentiment: Security / operational risk — A phishing attack in March compromised an employee account and exposed some customer contact, employee and corporate information; this raises short-term reputational and operational risk and could pressure sentiment until controls and remediation are clearly communicated. Intuitive Surgical Maintains Edge Despite Security Breach
• Negative Sentiment: Analyst downgrade — Zacks cut ISRG from “strong-buy” to “hold,” which can reduce short-term buying pressure from model-driven funds and investor groups that track analyst sentiment. Zacks.com

Analysts Set New Price Targets

Several equities analysts have commented on the company. Evercore dropped their target price on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research report on Friday, January 23rd. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. HSBC raised their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a report on Monday, January 26th. Finally, Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price on the stock in a research report on Wednesday, March 11th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $614.95.

Intuitive Surgical Stock Up 0.8%

Shares of NASDAQ:ISRG opened at $464.45 on Thursday. The firm has a market cap of $164.94 billion, a P/E ratio of 58.87, a P/E/G ratio of 3.56 and a beta of 1.68. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The business has a fifty day simple moving average of $490.34 and a 200 day simple moving average of $513.40.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.21 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.